|Bid||44.92 x 900|
|Ask||45.51 x 1400|
|Day's range||44.92 - 45.31|
|52-week range||36.90 - 90.92|
|Beta (5Y monthly)||0.07|
|PE ratio (TTM)||95.74|
|Earnings date||11 Apr 2022 - 15 Apr 2022|
|Forward dividend & yield||0.24 (0.49%)|
|Ex-dividend date||22 Oct 2021|
|1y target est||59.25|
LANCASTER, Calif., January 20, 2022--Simulations Plus enters another new funded collaboration to enhance GastroPlus and advance research into new treatments for gastrointestinal diseases.
LANCASTER, Calif., January 13, 2022--Simulations Plus announced that a new funded collaboration will enhance GastroPlus to support veterinary medicine and alternatives to animal testing.
LANCASTER, Calif., January 12, 2022--Simulations Plus CEO Shawn O'Connor will be presenting and meeting investors at the virtual Sidoti Winter Small Cap Investor Conference, Jan. 19-20.